Dosing and Enrollment Complete for First Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial by Advaxis.

0 Comments | M2 Presswire, November, 2006

M2 PRESSWIRE-14 November 2006-StockProfiler.US: Dosing and Enrollment Complete for First Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial by Advaxis(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:14112006 New York, NY - Advanced Technetix, Inc. (Pink Sheets: AVXN); Advanced Viral Research Corp.

(OTCBB: ADVR); Advaxis (OTCBB: ADXS); Aegis Assessments, Inc. (OTCBB: AGSI); Aegis Communications Group, Inc. (OTCBB: AGIS); Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) Do Investor's Know What You and Your Company are About? StockProfiler.US is pleased to offer its Market Awareness services to CEO's abroad. StockProfiler.US places publicly traded companies in the forefront of the investment community. We are dedicated to bringing brokers, investors and...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)